NO881151L - Syntetisk hiv-1-antigen. - Google Patents

Syntetisk hiv-1-antigen.

Info

Publication number
NO881151L
NO881151L NO881151A NO881151A NO881151L NO 881151 L NO881151 L NO 881151L NO 881151 A NO881151 A NO 881151A NO 881151 A NO881151 A NO 881151A NO 881151 L NO881151 L NO 881151L
Authority
NO
Norway
Prior art keywords
hiv
antigen
synthetic hiv
useful
immunologically reactive
Prior art date
Application number
NO881151A
Other languages
English (en)
Other versions
NO881151D0 (no
Inventor
Anders Vahlne
Bo Svennerholm
Lars Rymo
Stig Jeansson
Peter Horal
Original Assignee
Syntello Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8701294A external-priority patent/SE468181B/sv
Application filed by Syntello Ab filed Critical Syntello Ab
Publication of NO881151D0 publication Critical patent/NO881151D0/no
Publication of NO881151L publication Critical patent/NO881151L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Det er skaffet tilveie syntetiske peptidervarende til om-råder av immunologisk reaktive proteiner av HIV-1. Peptider som er immunologisk reaktive med HIV-1 spesifikke antilegemer er nyttige og anvendelige i analyser for påvisning av HIV-1 infeksjon eller eksponering og i sammensetninger for é frembringe eller utlese produksjonen av antilegemer mot HIV-1 i dyr, herunder mennesker.
NO881151A 1987-03-27 1988-03-16 Syntetisk hiv-1-antigen. NO881151L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8701294A SE468181B (sv) 1987-03-27 1987-03-27 Hiv-1 gp41 peptid, vaccin och antigen innehaallande peptiden jaemte diagnostiskt test med peptiden
US5172687A 1987-05-18 1987-05-18

Publications (2)

Publication Number Publication Date
NO881151D0 NO881151D0 (no) 1988-03-16
NO881151L true NO881151L (no) 1988-09-28

Family

ID=26659756

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881151A NO881151L (no) 1987-03-27 1988-03-16 Syntetisk hiv-1-antigen.

Country Status (9)

Country Link
EP (1) EP0284587A3 (no)
AU (1) AU606928B2 (no)
CA (1) CA1336473C (no)
DK (1) DK164088A (no)
ES (1) ES2013328A6 (no)
FI (1) FI881418A (no)
NO (1) NO881151L (no)
NZ (1) NZ224046A (no)
RU (1) RU1802871C (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
US5128319A (en) 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
AU629528B2 (en) * 1988-01-27 1992-10-08 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting hiv antibodies
US5204259A (en) * 1988-05-06 1993-04-20 Pharmacia Genetic Engineering, Inc. Methods and systems for producing HIV antigens
ATE134195T1 (de) * 1988-06-10 1996-02-15 United Biomedical Inc Peptidfragmente von hiv
JPH0292298A (ja) * 1988-09-30 1990-04-03 Olympus Optical Co Ltd Ｈｉｖ構成蛋白に対するモノクローナル抗体
SE8900721D0 (sv) * 1989-03-02 1989-03-02 Blomberg Jonas Methods for detection of antibodies to
GB8918200D0 (en) * 1989-08-09 1989-09-20 Medical Res Council The peptide fragments of hiv
NZ235538A (en) * 1989-10-12 1992-06-25 Viral Technologies Inc Peptides immunoreactive with antibodies to hiv p17; carrier-bound peptides, vaccines, immunoassay and a method for forming antibody enriched sera
AU6887591A (en) * 1989-11-27 1991-06-26 Replico Medical Aktiebolag New hiv-1 p17 peptides, diagnostic antigens and immunoassay method
CA2072351A1 (en) * 1990-01-05 1991-07-06 Andrew J. Mcmichael Hiv-1 core protein fragments
US5427907A (en) * 1990-02-23 1995-06-27 Virginia Commonwealth University Assay for equine infectious anemia virus
DE4039925A1 (de) * 1990-12-14 1992-06-17 Behringwerke Ag Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung
US6479055B1 (en) 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
FR2731225B1 (fr) * 1995-03-03 2003-10-31 Pasteur Institut Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique
JP4278174B2 (ja) * 1994-10-20 2009-06-10 アンスティテュ・パストゥール Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列
FR2734281B1 (fr) * 1995-05-18 1997-07-25 Commissariat Energie Atomique Fragments d'acide nucleique derives du genome du virus vih-1, peptides correspondants et leurs applications en tant que reactifs d'evaluation du risque de transmission materno-foetale du vih-1
EP1131633A2 (en) 1998-11-16 2001-09-12 Board of Regents, The University of Texas System Hiv-specific t-cell induction
US6824837B2 (en) 2001-09-04 2004-11-30 Wisconsin Alumni Research Foundation Liquid crystal switching mechanism
US7807348B2 (en) 2002-03-20 2010-10-05 Wisconsin Alumni Research Foundation Optical imaging of nanostructured substrates
US7125592B2 (en) 2002-04-10 2006-10-24 Wisconsin Alumni Research Foundation Detecting interactions at biomimetic interfaces with liquid crystals
WO2004044583A1 (en) 2002-11-08 2004-05-27 Wisconsin Alumni Research Foundation Surfaces with gradients in surface topography
US7303694B2 (en) 2003-07-17 2007-12-04 Wisconsin Alumni Research Foundation Liquid crystals with reduced toxicity and applications thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0201540B2 (en) * 1984-10-18 2001-10-31 Institut Pasteur Envelope antigens of lymphadenopathy associated virus and their applications
US4774175A (en) * 1985-03-01 1988-09-27 Centocor, Inc. Immunochemical methods for the detection of antibody against HTLV-III
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
DE3650175T3 (de) * 1985-04-29 2007-09-06 Bio-Rad Laboratories, Inc., Hercules Synthetische antigene zum nachweis von aids.
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
JPS63502904A (ja) * 1986-03-24 1988-10-27 オ−ソ・フア−マシユ−チカル・コ−ポレ−シヨン 合成ｈｔｌｖ−３ペプチド、その組成物及び用途
AU617088B2 (en) * 1986-06-12 1991-11-21 Biogen, Inc. Peptides involved in the pathogenesis of hiv infection

Also Published As

Publication number Publication date
FI881418A0 (fi) 1988-03-24
RU1802871C (ru) 1993-03-15
FI881418A (fi) 1988-09-28
DK164088A (da) 1988-09-28
CA1336473C (en) 1995-07-25
EP0284587A2 (en) 1988-09-28
AU606928B2 (en) 1991-02-21
ES2013328A6 (es) 1990-05-01
NO881151D0 (no) 1988-03-16
EP0284587A3 (en) 1990-11-22
AU1380788A (en) 1988-09-29
NZ224046A (en) 1990-07-26
DK164088D0 (da) 1988-03-25

Similar Documents

Publication Publication Date Title
NO881151L (no) Syntetisk hiv-1-antigen.
KR900700507A (ko) Htlv-1 감염 검출용 합성 펩티드 항원
FI870447A (fi) Htlv-iii-hoeljepeptider.
NO881719L (no) Syntetisk hiv-2-antigen.
DK532284A (da) Fremgangsmaade til bestemmelse af antigenaktive aminosyresekvenser
DE69334148D1 (de) HIV-Peptide
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
ATE126594T1 (de) Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen.
ES2080047T3 (es) Peptidos hiv y metodos para la deteccion de hiv.
SE8902148D0 (sv) Syntetiska peptid antigen foer detektion av htlv-1 infektion
ATE119203T1 (de) Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus.
GR3033885T3 (en) Synthetic antigens for the detection of aids-related disease caused by LAV-2.
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
IT1141277B (it) Polipeptide sintetico attivo come antigene,e procedimento per la sua preparazione
FI102834B1 (fi) Kysteiinitioli-suojatut peptidit käytettäviksi immunologisissa määrityksissä
DE68926813D1 (de) Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide
UA10353A (uk) Спосіб діагhостики адеhовірусhої іhфекції у дітей
MX9204271A (es) Prueba inmunoenzimatica para deteccion de anticuerpo vih-1.